Related Experiment Videos
[Anticancer drug sensitivity tested by tumor stem cell assay]
Gan No Rinsho. Japan Journal of Cancer Clinics
|July 1, 1984
Summary
The tumor stem cell assay accurately predicts anticancer drug effectiveness for individual cancer patients. This method shows high correlation with in vivo results, aiding chemotherapy selection and drug screening.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Context:
- Accurate in vitro anticancer drug sensitivity testing is crucial for effective chemotherapy.
- Individualized cancer treatment requires reliable methods to predict drug response.
- The tumor stem cell assay offers a potential solution for personalized medicine in oncology.
Purpose:
- To evaluate the tumor stem cell assay for selecting effective anticancer drugs for individual patients.
- To assess the utility of the tumor stem cell assay for in vitro phase II screening of novel anticancer agents.
- To determine the correlation between in vitro drug sensitivity and in vivo patient response.
Summary:
- The study evaluated the tumor stem cell assay using 66 cancer patient specimens.
- The assay demonstrated excellent in vitro anticancer drug sensitivity testing capabilities.
- In vitro results showed a 93% correlation with in vivo patient response data and a 100% true negative rate.
Impact:
- This assay can guide the selection of effective chemotherapy drugs for individual cancer patients.
- It provides a reliable platform for the in vitro phase II screening of new anticancer drugs.
- The high accuracy and correlation with in vivo data support its clinical application in oncology.